Leuprolide

Back to search

Molecule Structure

Scientific Name

Leuprolide

Description of the Drug

Leuprolide is a peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00007

Brand Name(s)

Not Available

Company Owner(s)

Tolmar Therapeutics Inc, Sandoz Inc, Ortho Mcneil Janssen Pharmaceutical Inc, Invagen Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Vgyaan Pharmaceuticals Llc, Genzyme Corporation, Accord Biopharma Inc, Eugia Pharma Specialities Ltd, Abbvie Endocrine Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Gonadotropin-releasing hormone receptor SINGLE PROTEIN AGONIST CHEMBL1855

Unichem Links

SureChEMBL SCHEMBL4585
Human Metabolome Database HMDB0041916
DrugBank DB00007
PubChem: Thomson Pharma 14841815 14939439 14939438 14890460
PubChem 657181
Nikkaji J34.477J
BindingDB 50369395
EPA CompTox Dashboard DTXSID50872411
DrugCentral 1559
ChemicalBook CB8398455
Guide to Pharmacology 1175
rxnorm LEUPROLIDE ACETATE LUPRON ELIGARD LEUPROLIDE
ChEBI 6427